This article was originally published on Chief Healthcare Executive.
Healthcare organizations are navigating unprecedented financial pressure, operational complexity, and heightened expectations for accountability.
While clinical supply chains have benefited from decades of standardization and discipline, one of the largest remaining opportunities sits outside the traditional spotlight: non-clinical purchased services.
Facilities management, environmental services, IT services, consulting, revenue cycle support, outsourced labor, and other professional services collectively represent roughly 20–22% of a health system’s total operating revenue. Despite their scale, these categories often operate with limited visibility, fragmented governance, and inconsistent strategic oversight.
The challenge is not that purchased services lack importance. It is that they are complex, relationship-driven, and historically difficult to manage at scale. As a result, they have frequently been treated as operational necessities rather than strategic levers.
In today’s margin-constrained environment, that mindset is no longer sustainable. Purchased services represent one of healthcare’s most under-leveraged opportunities to unlock value, improve performance, and accelerate execution.
Organizations that succeed in this space do not rely on incremental negotiation tactics. They apply leadership discipline, establish clear governance, and pair visibility with deep category expertise. In doing so, they move from reactive cost management to proactive value creation.
In practice, leaders who align internal intent with external category intelligence, often through specialized partners, are able to surface insights faster, challenge legacy assumptions, and translate data into sustained results. The outcome is not simply cost reduction, but clarity: clarity that enables better decisions, stronger accountability, and repeatable impact.
As financial pressure intensifies and organizational complexity grows, velocity becomes a differentiator. Health systems that are willing to elevate non-clinical procurement to the executive agenda and act decisively will distinguish themselves through resilience and agility.
The opportunity is substantial. The tools exist. For leaders prepared to look beyond traditional boundaries, the returns from reimagining non-clinical procurement can be transformative.
See how our approach can help unlock savings across non-clinical spend and drive margin improvement.



